[VRDN] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
13-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 13.44%
YoY- -70.06%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 72 72 72 72 72 98 105 -22.25%
PBT -64,993 -48,542 -66,860 -47,660 -55,063 -68,151 -45,785 26.33%
Tax 0 -145 5,534 -135 4,378 -105 -3,281 -
NP -64,993 -48,542 -66,860 -47,660 -55,063 -68,046 -42,504 32.76%
Tax Rate - - - - - - - -
Total Cost 65,065 48,614 66,932 47,732 55,135 68,144 42,609 32.64%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -90,268.05 -67,419.44 -92,861.11 -66,194.44 -76,476.39 -69,434.69 -40,480.00 70.76%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -1.02 -0.79 -1.35 -1.09 -1.27 -1.61 -1.05 -1.91%
EPS Diluted -1.02 -0.79 -1.35 -1.09 -1.27 -1.61 -1.05 -1.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.